Aug 31 (Reuters) – Abbisko Cayman Limited: * THERAPEUTICS COMPLETES FIRST PATIENT DOSING IN PHASE I TRIAL OF ABSK211 Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Mumbai (Maharashtra) [India], October 20: Aayush Wellness Limited, an integrated healthcare company, has expanded its…
Flick clarifies Barcelona backline options amid injury crisis
VIDEO SHOWS: BARCELONA HOLD TRAINING SESSION AND PRESS CONFERENCE A DAY AHEAD OF FACING PARIS…
Polish industrial output rises 4.6% y/y in September, above expectations
Oct 20 (Reuters) - The following are Polish industrial output data for September released by…
